IDEAYA Biosciences, Inc. , a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
Ideaya Biosciences stock last closed at $34.27, down 1.49% from the previous day, and has increased 79.14% in one year. It has overperformed other stocks in the Biotechnology industry by 1.06 percentage points. Ideaya Biosciences stock is currently +154.8% from its 52-week low of $13.45, and -12.75% from its 52-week high of $39.28.
As of Mar 17, 2026, there are 87.81M IDYA shares outstanding. The market capitalization of IDYA is $3.01B. In the last 24 hours, 958,000 IDYA shares were traded.
How to Buy Ideaya Biosciences Stock
Wondering how to invest in Ideaya Biosciences stock? Here's how.
Decide where to buy Ideaya Biosciences stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Ideaya Biosciences stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Fund your investment account: Choose your method of payment and add your info.
Evaluate Ideaya Biosciences stock: The Ideaya Biosciences ticker symbol is IDYA. Is Ideaya Biosciences stock a good investment? Should you buy shares of IDYA? How do IDYA's underlying business fundamentals look? Do top analysts think Ideaya Biosciences is a good buy? Why has IDYA's stock price moved recently? (Hint: Our stock market analysis website can help you decide if IDYA is a good stock to buy).
Execute your IDYA purchase: Decide if you will purchase IDYA shares at the current market price or use a limit order to buy IDYA stock at a specific price.
Keep an eye on your IDYA position: Create a watchlist to the latest updates on your investment in Ideaya Biosciences shares.
Step 1: Decide where to buy Ideaya Biosciences stock
You need an online brokerage account to access the NASDAQ market and buy IDYA stock.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world markets: From Technology to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal details so you are able to invest in IDYA stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Ideaya Biosciences stock
After you have figured out the best place to buy Ideaya Biosciences stock, it's important to analyze their stock prior to investing, so you actually understand the risk as well as the upside.
Ideaya Biosciences Metrics
IDYA Price
$34.27
1w %
-1.35%
1y %
79.14%
5y %
46.2%
P/E
-26.77x
P/B
2.94x
P/S
13.86x
PEG
N/A
Revenue
$218.71M
Earnings
-$113.70M
Fore. Rev. Growth
-0.17%
Fore. Earn. Growth
N/A
Market Cap
$3.01B
Next Earnings
Mar 31, 2026
Next Dividend
N/A
Ideaya Biosciences Overview
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
There are more short-term assets than short-term liabilities on the IDYA balance sheet.
IDYA has a low debt to equity ratio of 0.08.
There are more short-term assets than long-term liabilities on the IDYA balance sheet.
Total IDYA debt is lower than 5 years ago, relative to shareholder equity.
IDYA has $640.40M in cash and short term investments. This is enough to cover its annual cash burn of $73.47M.
IDYA has cash burn of 73466000. It has enough cash and short-term investments to cover this for at least one year.
Negative Health Checks:
IDYA profit margin has gone up by 38.69 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy IDYA stock, according to Wall Street analysts?
Out of 10 sell side analysts who monitor IDYA, the consensus analyst rating on IDYA is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Latest IDYA Analyst Ratings
Gregory Renza, a top 3% analyst from Truist Securities maintains IDYA with a strong buy rating and raises their IDYA price target from $59.00 to $60.00, on Jan 6, 2026.
Truist Securities's Gregory Renza raised their price target on Ideaya Biosciences (NASDAQ: IDYA) by 1.7% from $59 to $60 on 2026/01/06. The analyst maintained their Strong Buy rating on the stock.
Renza contextualized their price target hike on "Top Idea" Ideaya Biosciences by telling readers that:
The company is approaching a key near-term catalyst with Daro's topline progression free survival readout in first line uveal melanoma in Q1 2026.
Strong Phase II data and supportive key opinion leader feedback make the setup attractive, with an 85% probability of success in Good/Best Case scenarios and potential 15% to 25% upside.
Graig Suvannavejh, a top 6% analyst from Mizuho maintains IDYA with a buy rating and raises their IDYA price target from $44.00 to $46.00, on Nov 11, 2025.
Anupam Rama, a top 4% analyst from JP Morgan maintains IDYA with a strong buy rating and raises their IDYA price target from $74.00 to $79.00, on Oct 23, 2025.
Corinne Jenkins, a top 28% analyst from Goldman Sachs maintains IDYA with a hold rating and raises their IDYA price target from $27.00 to $30.00, on Oct 21, 2025.
Justin Zelin, a bottom 24% analyst from BTIG reiterates IDYA with a strong buy rating and maintains their IDYA price target from $62.00 to $62.00, on Oct 21, 2025.
Last year, IDYA revenue was $218.71M. During the last five year, IDYA's revenue has grown by 62.11% per year. This was faster than the Biotechnology industry average of 28.23%.
No, Ideaya Biosciences doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your IDYA purchase
You have two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are generally the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a given price limit, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you want additional assistance buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Ideaya Biosciences share?
As of Mar 17, 2026, it costs $34.27 to buy one share of Ideaya Biosciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.292 shares of IDYA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.